IL-5–Inhibiting Agents Mepolizumab, Benralizumab, and Reslizumab – AJMC.com Managed Markets Network

IL-5–Inhibiting Agents Mepolizumab, Benralizumab, and Reslizumab – AJMC.com Managed Markets Network

IL-5–Inhibiting Agents Mepolizumab, Benralizumab, and Reslizumab – AJMC.com Managed Markets Network
Published on 2019-02-22